Clearly this is just another political hit job:
A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Trump as a “game changer” in the fight against the virus had a significantly higher risk of death compared with those who did not.
People treated with hydroxychloroquine, or the closely related drug chloroquine, were also more likely to develop a type of irregular heart rhythm, or arrhythmia, that can lead to sudden cardiac death, it concluded.
The study, published Friday in the medical journal the Lancet, is the largest analysis to date of the risks and benefits of treating covid-19 patients with antimalarial drugs.
Read the full article.
Antimalarial drug touted by Pres Trump is linked to increased risk of death in coronavirus patients, according to one study. An analysis of 96K patients shows those treated with hydroxychloroquine were also more likely to suffer irregular heart rhythms. https://t.co/XfW8r7KIe6
— Yamiche Alcindor (@Yamiche) May 22, 2020
Q. What the hell do you have to lose?
A. Study of 96,000 coronavirus patients found that those who received hydroxychloroquine had a significantly higher risk of death and were also more likely to develop arrhythmia, which can lead to sudden death. https://t.co/hCMcljxhYk
— Tommy Vietor (@TVietor08) May 22, 2020
“For those receiving hydroxychloroquine and an antibiotic — the cocktail endorsed by Trump — there was a 45 percent increased risk of death and a 411 percent increased risk of serious heart arrhythmias.” https://t.co/XCLxor70z7
— Willie Geist (@WillieGeist) May 22, 2020
This huge study in @TheLancet found ZERO BENEFIT of #hydroxychloroquine or #chloroquine, but people treated with either drug were MORE LIKELY to develop a type of potentially FATAL irregular heart rhythm (ventricular arrhythmia), that can lead to sudden cardiac death.💥 pic.twitter.com/CCtiYt3qT1
— Dr. Dena Grayson (@DrDenaGrayson) May 22, 2020